343 related articles for article (PubMed ID: 14962743)
1. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Pillot T
Mol Cell Neurosci; 2004 Jan; 25(1):95-102. PubMed ID: 14962743
[TBL] [Abstract][Full Text] [Related]
2. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
[TBL] [Abstract][Full Text] [Related]
3. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of [Gly14]-Humanin on beta-amyloid-induced PC12 cell death by preventing mitochondrial dysfunction.
Jin H; Liu T; Wang WX; Xu JH; Yang PB; Lu HX; Sun QR; Hu HT
Neurochem Int; 2010 Feb; 56(3):417-23. PubMed ID: 19941922
[TBL] [Abstract][Full Text] [Related]
5. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
[TBL] [Abstract][Full Text] [Related]
6. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
[TBL] [Abstract][Full Text] [Related]
7. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.
Ferreiro E; Resende R; Costa R; Oliveira CR; Pereira CM
Neurobiol Dis; 2006 Sep; 23(3):669-78. PubMed ID: 16844381
[TBL] [Abstract][Full Text] [Related]
8. Overactivation of calcineurin induced by amyloid-beta and prion proteins.
Agostinho P; Lopes JP; Velez Z; Oliveira CR
Neurochem Int; 2008 May; 52(6):1226-33. PubMed ID: 18295934
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxicity of the putative transmembrane domain of the prion protein.
Haïk S; Peyrin JM; Lins L; Rosseneu MY; Brasseur R; Langeveld JP; Tagliavini F; Deslys JP; Lasmézas C; Dormont D
Neurobiol Dis; 2000 Dec; 7(6 Pt B):644-56. PubMed ID: 11114262
[TBL] [Abstract][Full Text] [Related]
10. Activation of the JNK-c-Jun pathway during the early phase of neuronal apoptosis induced by PrP106-126 and prion infection.
Carimalo J; Cronier S; Petit G; Peyrin JM; Boukhtouche F; Arbez N; Lemaigre-Dubreuil Y; Brugg B; Miquel MC
Eur J Neurosci; 2005 May; 21(9):2311-9. PubMed ID: 15932590
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo neurotoxicity of prion protein oligomers.
Simoneau S; Rezaei H; Salès N; Kaiser-Schulz G; Lefebvre-Roque M; Vidal C; Fournier JG; Comte J; Wopfner F; Grosclaude J; Schätzl H; Lasmézas CI
PLoS Pathog; 2007 Aug; 3(8):e125. PubMed ID: 17784787
[TBL] [Abstract][Full Text] [Related]
12. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
[TBL] [Abstract][Full Text] [Related]
13. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
14. Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106-126.
Sassoon J; Daniels M; Brown DR
Mol Cell Neurosci; 2004 Jan; 25(1):181-91. PubMed ID: 14962751
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil.
Takada-Takatori Y; Kume T; Ohgi Y; Izumi Y; Niidome T; Fujii T; Sugimoto H; Akaike A
J Neurosci Res; 2008 Dec; 86(16):3575-83. PubMed ID: 18655200
[TBL] [Abstract][Full Text] [Related]
16. Involvement of mitochondria in endoplasmic reticulum stress-induced apoptotic cell death pathway triggered by the prion peptide PrP(106-126).
Ferreiro E; Costa R; Marques S; Cardoso SM; Oliveira CR; Pereira CM
J Neurochem; 2008 Feb; 104(3):766-76. PubMed ID: 17995926
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.
Chabry J; Ratsimanohatra C; Sponne I; Elena PP; Vincent JP; Pillot T
J Neurosci; 2003 Jan; 23(2):462-9. PubMed ID: 12533606
[TBL] [Abstract][Full Text] [Related]
18. Fibrillar prion peptide PrP(106-126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons.
Gavín R; Ureña J; Rangel A; Pastrana MA; Requena JR; Soriano E; Aguzzi A; Del Río JA
Neurobiol Dis; 2008 May; 30(2):243-54. PubMed ID: 18374587
[TBL] [Abstract][Full Text] [Related]
19. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
[TBL] [Abstract][Full Text] [Related]
20. Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126).
Perovic S; Schröder HC; Pergande G; Ushijima H; Müller WE
Exp Neurol; 1997 Oct; 147(2):518-24. PubMed ID: 9344576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
